Related Experiment Video
Updated: Mar 13, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
Melanoma antigen-A11 regulates substrate-specificity of Skp2-mediated protein degradation
Shifeng Su1, Xiaoyu Chen1, Jiang Geng1
1Laboratories for Reproductive Biology, Department of Pediatrics, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA.
Abstract:
Melanoma antigen-A11 (MAGE-A11) is a proto-oncogene involved in androgen receptor signaling and androgen-dependent cell growth. In this report we provide evidence that MAGE-A11 interacts with Skp2 (S phase kinase-associated protein), the substrate recognition protein of the Skp1-Cullin1-F-box E3 ubiquitin ligase, and with Skp2 binding protein, cyclin A. A similar cyclin A binding motif in MAGE-A11 and Skp2 was consistent with a competitive relationship between MAGE-A11 and Skp2 in binding cyclin A. Skp2 inhibited MAGE-A11 interaction with cyclin A. Differential effects of MAGE-A11 on Skp2-mediated protein degradation were also revealed. MAGE-A11 increased Skp2-mediated degradation of cyclin A and retinoblastoma-related protein p130. In contrast, MAGE-A11 decreased Skp2-mediated degradation of E2F1 and Skp2 self-ubiquitination. Stabilization of E2F1 by MAGE-A11 was associated with sequestration and inactivation of Skp2 through the formation of an E2F1-MAGE-A11-Skp2 complex. We conclude that direct interactions of MAGE-A11 with Skp2 and cyclin A regulate the substrate-specificity of Skp2-mediated protein degradation.
Insights
Melanoma antigen-A11 (MAGE-A11) interacts with Skp2 and cyclin A, influencing protein degradation. MAGE-A11 stabilizes E2F1 by forming a complex with Skp2, regulating Skp2
Area of Science:
- Oncology
- Molecular Biology
- Cellular Biology
Background:
- Melanoma antigen-A11 (MAGE-A11) is a proto-oncogene implicated in androgen receptor signaling and androgen-dependent cell growth.
- Understanding MAGE-A11's molecular interactions is crucial for elucidating its role in cancer progression.
Purpose of the Study:
- To investigate the interaction between MAGE-A11, Skp2 (S phase kinase-associated protein), and cyclin A.
- To determine the functional consequences of MAGE-A11's interaction with the Skp2-Cullin1-F-box E3 ubiquitin ligase complex on substrate protein degradation.
Main Methods:
- Co-immunoprecipitation assays to demonstrate physical interactions between MAGE-A11, Skp2, and cyclin A.
- Analysis of Skp2-mediated protein degradation in the presence and absence of MAGE-A11.
- Assessment of E2F1 protein levels and Skp2 self-ubiquitination.
Main Results:
- MAGE-A11 directly interacts with both Skp2 and cyclin A, exhibiting a competitive binding relationship for cyclin A.
- MAGE-A11 modulates Skp2-mediated degradation, increasing the degradation of cyclin A and p130, while decreasing the degradation of E2F1.
- MAGE-A11 stabilizes E2F1 by forming a ternary complex (E2F1-MAGE-A11-Skp2), sequestering and inactivating Skp2.
Conclusions:
- MAGE-A11 directly interacts with Skp2 and cyclin A, thereby regulating the substrate specificity of the Skp2-Cullin1-F-box E3 ubiquitin ligase.
- These interactions offer a novel mechanism by which MAGE-A11 influences cell growth and potentially cancer development by controlling key protein degradation pathways.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Intrinsic Apoptotic Pathway
Anaphase Promoting Complex
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

